(1S,1'S,3S)-3-CARBOXY-1-(1',2'-DIHYDROXYETHYL)-6,7-DIHYDROXY-,1,2,3,4-TETRAHYDROISOQUINOLINE
Compound with spectra: 1 NMR
| SpectraBase Compound ID | EVjucQNudWD |
|---|---|
| InChI | InChI=1S/C12H15NO6/c14-4-10(17)11-6-3-9(16)8(15)2-5(6)1-7(13-11)12(18)19/h2-3,7,10-11,13-17H,1,4H2,(H,18,19)/t7-,10-,11-/m0/s1 |
| InChIKey | DCJLAZTZJRNILL-SWPVVBRQSA-N |
| Mol Weight | 269.25 g/mol |
| Molecular Formula | C12H15NO6 |
| Exact Mass | 269.089937 g/mol |
| Enantiomer InChIKey | DCJLAZTZJRNILL-AVPPRXQKSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
6,7-Dihydroxy-1-(1,2,3,4,5-pentahydroxy-pentyl)-tetrahydro-isoquinolinium cation, major diastereomer
3-Carboxy-1-(4-hydroxy-benzyl)-6,8-dihydroxy-tetrahydro-isoquinoline
PMJOKUUJAHPZFM-ZIAGYGMSSA-N
2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-1-yl)hexanoic acid
(1R,2R)-1-(4-hydroxybenzyl)-2-methyl-2-oxido-3,4-dihydro-1H-isoquinolin-2-ium-6,7-diol
LAUDANINE
(+)-LAUDANIDINE
UCXJKPFHCVJKKF-GFCCVEGCSA-N
N-METHYL-1-BENZYL-6-BENZYLOXY-7-METHOXY-1,2,3,4-TETRAHYDRO-ISOQUINOLINE
| Title | Journal or Book | Year |
|---|---|---|
| Pictet–Spengler condensation of the antiparkinsonian drug l-DOPA with d-glyceraldehyde. Opposite kinetic effects of Fe3+ and Cu2+ ions and possible implications for the origin of therapeutic side effects | Bioorganic & Medicinal Chemistry | 2001 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.